VIDO says it has taken another step forward in developing a made-in-Canada COVID-19 vaccine.The Saskatoon-based science and research facility said 108 volunteers have been selected to take part in its COVAC-2 vaccine trial.“We are excited to start clinical trials,” VIDO director Dr.
Volker Gerdts said Wednesday in a statement.“Our team has worked hard to advance the development of this vaccine to help combat the COVID-19 pandemic.” VIDO-InterVac vaccine in clinical trials, production facility operational next year The Canadian Center for Vaccinology (CCfV) in Halifax is undertaking the trial and said volunteers will be administered two doses 28 days apart in a placebo-controlled study.“The goal of this trial is to help demonstrate vaccine.